EUSA Pharma Announces FDA Approval of Phase 3 Clinical Trial for Siltuximab in Hospitalized Patients With COVID-19 Associated Acute Respiratory Distress Syndrome

View Full Size 

Download

• Full Size JPEG, 1024x219, 23.1 KB
• Small JPEG, 480x103, 7.8 KB
• Preview JPEG, 144x31, 1.7 KB
• Thumbnail JPEG, 120x26, 1.3 KB